EFFECTS OF FIELD SIZE AND DEPTH ON PHOTONEUTRON DOSE EQUIVALENT DISTRIBUTIONS IN AN 18 MV X-RAY MEDICAL ACCELERATOR

Whole-body photoneutron 360° angular distribution dosimetry by novel "Sohrabi neutron dosimetry methods"

PURPOSE

Whole-body photoneutron (PN) energy-specific dosimetry on phantom surfaces and 360°angular fast PN distribution dosimetry on and around polyethylene (PE) phantom organs for prostate cancer in 10 cm × 10 cm and 20 cm × 20 cm field sizes of 18 MV X-rays of Varian Clinac 2100C linear accelerator.

METHODS

Novel "Sohrabi neutron dosimetry methods" including "miniature passive neutron dosimeter/spectrometer" and "strip polycarbonate neutron dosimeters" were applied. Energy-specific PN dose equivalents on surface as well as 360°fast PN dose equivalent angular distributions on and around PE phantom organs; head, neck, thorax, arms, pelvis, thighs and legs were determined.

RESULTS

Matrix of surface (skin) energy-specific PN dose equivalents including total thermal, total epithermal, total fast, sum total thermal + epithermal and sum total thermal + epithermal + fast, and 360°angular fast PN dose equivalent responses were determined. The results indicate that data matrix of 20 cm × 20 cm field size provides higher PN dose equivalent values than those of 10 cm × 10 cm field size for surface points even remote from the central axis and for all 360°angular fast PN dose equivalent distributions on organs studied.

CONCLUSIONS

Matrix of energy-specific PN dose equivalents was obtained demonstrating that the Sohrabi neutron dosimetry methods applied are unique for energy-specific PN dose equivalent studies as well as for 360°angular PN dose equivalent distribution data for PN-SPC risk estimation. The dosimetry methods can be specifically applied to many other exotic applications in health physics, medical physics, space flight dosimetry, and nuclear science and technology.

Breakthrough whole body energy-specific and tissue-specific photoneutron dosimetry by novel miniature neutron dosimeter/spectrometer

Breakthrough whole body energy-specific photoneutron (PN) dosimetry was made in/out-of-field in polyethylene phantom organ surface/depths remote from isocenter of 10 × 10 cm2 field prostate cancer therapy in 18 MV X-rays Varian Clinac 2100C medical linear accelerator for PN tissue-specific second primary cancer (PN-SPC) risk estimation. A novel miniature neutron dosimeter/spectrometer with polycarbonate/10B/cadmium inserts was invented and applied. Each dosimeter determines seven tissue-specific dose equivalent (mSv)/Gy X-ray dose at each measurement point providing seven major energy-specific responses for beam thermal, albedo thermal, total thermal, total epithermal, total fast, sum of totals (thermal + epithermal) and sum of totals (thermal + epithermal + fast) PNs dose equivalents. The neutron dosimeter is simple, efficient, and unique with high spatial resolution and provides matrix of energy-specific PN dose equivalent (mSv)/Gy X-ray dose on surface and organ depths for tissue-specific PN-SPC risk estimation. The dosimeter also performs like a "miniature neutron spectrometer" and is unique for other applications in health physics in particular individual neutron dosimetry, medical physics, space flights, science and technology.

Photoneutron spectrometry by novel multi-directional spherical neutron spectrometry system

Neutron spectrometry in science and technology applications in general and accurate exotic photoneutron (PN) dosimetry of cancer patients undergoing high-dose high-energy X-rays therapy in medical accelerators in particular is of vital need. In this study, a novel passive multi-directional multi-detector neutron spectrometry system was developed and home-made using 6 polycarbonate/10B detectors on 6 sides of polyethylene (PE) cubes used bare and also embedded at center of PE spheres of 8 different diameters. The system provided well-resolved unfolded directional PN spectra showing thermal and fast PN peaks of 6 sides and mean spectrum in 5 field sizes at isocenter and other locations in 18 MV Siemens ONCOR medical linear accelerator bunker. The neutron spectrometry system developed has unique characteristics such as being simple, efficient, low cost, practical, and insensitive to low-LET radiation with well-resolved directional and mean spectra easily applicable in medicine, health, environment, science and technology in developing and developed laboratories.

Photon and photon–neutron experimental dosimetry in Grid therapy with 18 MV photon beams

Propose:

Spatially fractionated Grid radiation therapy (SFGRT) in an effective technique for bulky and radio-sensitive tumours. SFGRT using a constructed block has been used to evaluate the photon and photo-neutron (PN) dose measurement in 18-MV photon beam energy.

Methods and materials:

A mounted Grid block on to a Varian Clinac 2100c linear accelerator was used to perform photon dosimetry. The percentage depth dose, in-plane and cross-plane beam profile and output factor was measured by ionization chamber in water. The PN contamination was measured after photon dosimetry using the combination of thermoluminescence dosimetry types 600 and 700, and Polycarbonate Film dosimeters on the surface and in the maximum depth dose (dmax) of solid water™ slabs.

Results:

The valley-to-peak ration for 6 and 18 MV photon beams obtained from the beam profiles was ~35 and 72%, respectively. Fast and thermal PN equivalent dose decreased in the Grid field compared to an open field (without Grid).

Conclusion:

The Grid therapy dosimetry compared to the conventional radiotherapy (without the grid) the production of fast and thermal neutrons were reduced. Using of a Grid block in high-energy photon beams for a long period of the treatment continuously might be a new source of contamination due to the interaction of photon beam resulting the activation of the Grid block

NOVEL 'PHOTONEUTRON VOLUME DOSE EQUIVALENT' HYPOTHESIS AND METHODOLOGY FOR SECOND PRIMARY CANCER RISK ESTIMATION IN HIGH-ENERGY X-RAY MEDICAL ACCELERATORS

A novel 'photoneutron (PN) volume dose equivalent' methodology was hypothesized and applied for the first time for estimating PN second primary cancer (PN-SPC) risks in high-energy X-ray medical accelerators. Novel position-sensitive mega-size polycarbonate dosimeters with 10B converter (with or without cadmium covers) were applied for determining fast, epithermal and thermal PN dose equivalents at positions on phantom surface and depths. The methodology was applied to sites of tumors such as brain, stomach and prostate in 47 patients. The PN-SPC risks were estimated for specific organs/tissues using linear International Commission on Radiological Protection cancer risks and were compared with some available data. The corresponding PN-SPC risk estimates ranged from 1.450 × 10-3 to 1.901 cases per 10 000 persons per Gray. The method was applied to 47 patients for estimating PN-SPC risks in patients undergoing radiotherapy. The PN-SPC risk estimates well match those calculated by simulation but are comparatively different from those estimated by 'PN point dose equivalent' methods, as expected.

Fast, epithermal and thermal photoneutron dosimetry in air and in tissue equivalent phantom for a high-energy X-ray medical accelerator

Photoneutron (PN) dosimetry in fast, epithermal and thermal energy ranges originated from the beam and albedo neutrons in high-energy X-ray medical accelerators is highly important from scientific, technical, radiation protection and medical physics points of view. Detailed dose equivalents in the fast, epithermal and thermal PN energy ranges in air up to 2m as well as at 35 positions from the central axis of 12 cross sections of the phantom at different depths were determined in 18MV X-ray beams of a Siemens ONCOR accelerator. A novel dosimetry method based on polycarbonate track dosimeters (PCTD)/¹⁰B (with/without cadmium cover) was used to determine and separate different PN dose equivalents in air and in a multilayer polyethylene phantom. Dose equivalent distributions of PNs, as originated from the main beam and/or albedo PNs, on cross-plane, in-plane and diagonal axes in 10cm×10cm fields are reported. PN dose equivalent distributions on the 3 axes have their maxima at the isocenter. Epithermal and thermal PN depth dose equivalent distributions in the phantom for different positions studied peak at ∼3cm depth. The neutron dosimeters used for the first time in such studies are highly effective for separating dose equivalents of PNs in the studied energy ranges (beam and/or albedo). The PN dose equivalent data matrix made available in this paper is highly essential for detailed patient dosimetry in general and for estimating secondary cancer risks in particular.

Novel 6MV X-ray photoneutron detection and dosimetry of medical accelerators

PURPOSE

Dosimetry of fast, epithermal and thermal photoneutrons in 6MV X-ray beams of two medical accelerators were studied by novel dosimetry methods.

METHODS

A Siemens ONCOR and an Elekta COMPACT medical accelerators were used. Fast, epithermal and thermal photoneutron dose equivalents in 10cm×10cm 6MV X-rays fields were determined in air and on surface of a polyethylene phantom in X and Y directions. Polycarbonate dosimeters as bare or with enriched ¹⁰B convertors (with or without cadmium covers) were used applying a 50Hz-HV electrochemical etching method.

RESULTS

Fast, epithermal and thermal photoneutron dose equivalents were efficiently determined respectively as ∼1145.8, ∼45.3 and ∼170.6μSv in air and ∼1888.5, ∼96.1 and ∼640.6μSv on phantom per 100Gy X-rays at the isocenter of Siemens ONCOR accelerator in air. The dose equivalent is maximum at the isocenter which decreases as distance from it increases reaching a constant level. Tissue-to-air ratios are constants up to 15cm from the isocenter. No photoneutrons was detected in the Elekta COMPACT accelerator.

CONCLUSIONS

Fast, epithermal and thermal photoneutron dosimetry of 6MV X-rays were made by novel dosimetry methods in a Siemens ONCOR accelerator with sum dose equivalent per Gy of ∼0.0014% μSv with ∼0.21MeV mean energy at the isocenter; i.e. ∼150 times smaller than that of 18MV X-rays. This observation assures clinical safety of 6MV X-rays in particular in single-mode machines like Elekta COMPACT producing no photoneutrons due to no "beryllium exit window" in the head structure.

Photoneutron depth dose equivalent distributions in high-energy X-ray medical accelerators by a novel position-sensitive dosimeter

PURPOSE

The purpose of this study was to; (1) investigate employing a novel position-sensitive mega-size polycarbonate (MSPC) dosimeter for photoneutron (PN) depth, profile and dose equivalent distributions studies in a multilayer polyethylene phantom in a Siemens ONCOR accelerator, and (2) develop depth dose equivalent distribution matrix data at different depths and positions of the phantom for patient PN dose equivalent determination and in particular for PN secondary cancer risk estimation.

METHODS

Position-sensitive MSPC dosimeters were successfully exposed at 9 different depths of the phantom in a 10×10cm² X-ray field. The dosimeters were processed in mega-size electrochemical chambers at optimum conditions. Each MSPC dosimeter was placed at a known phantom depth for PN depth dose equivalents and profiles on transverse, longitudinal and diagonal axes and isodose equivalent distribution studies in and out of the X-ray beam.

RESULTS

PN dose equivalent distributions at any depth showed the highest value at the beam central axis and decreases as the distance increases. PN dose equivalent at any position studied in the axes has a maximum value on the phantom surface which decreases as depth increases due to flux reduction by multi-elastic scattering interactions.

CONCLUSIONS

Extensive PN dose equivalent matrix data at different depths and positions in the phantom were determined. The position-sensitive MSPC dosimeters proved to be highly efficient for PN depth, profile and isodose equivalent distribution studies. The extensive data obtained highly assists for determining PN dose equivalent of a patient undergoing high-energy X-ray therapy and for PN secondary cancer risk estimation.